Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
US8283151B2 · kind B2 · utility
57Cited by
15References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2006 |
| Grant date | Oct 9, 2012 |
| Priority date | — |
| Expiry date | Feb 1, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides new adeno-associated virus (AAV) viruses and vectors, and particles derived therefrom. In addition, the present invention provides methods of delivering a nucleic acid to a cell using the AAV vectors and particles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.